Pharmacology: Neruodegenerative Disorders Flashcards

1
Q

What are the four classes of medications used in Alzheimer’s patients?

A

1) cholinesterase inhbitors
- prevents break down of ACh

2) memantine
- memory and cognition retention via upregulating glutamate in specific areas.

3) antidepressants
- patients get depressed so this helps it

4) anti anxiety
- patients often get angry or anxious so this helps

  • goal is to delay he progression for the disease, not to treat *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Donepezil, galantamine, rivastigmine, tacrine

Acetylcholinesterase inhibitors

A

MOA: prevents catabolism of ACh in the brain

  • effect is directly proportional to the number of intact cholinergic neurons left.
  • gets less effective as Alzheimer’s progresses.

PK:
- is reversible (except for rivastigmine)
- tacrine is no longer in use in the US
(liver damage)

Pregnancy C

Indications:
- mild to moderate Alzheimer’s

ADRs/contraindications

  • nausea/vomiting/cramping
  • GI hemorrhage
  • titration is often needed and people can be discontuied because of this
  • CANT USE:
    1) asthma/COPD
    2) CAD
    3) hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pathology of Alzheimer’s

A

B-amyloid proteins inhibit glutamate recycling into glia cells

Causes excess glutamate and masks the signal transmission due to down regulation of NMDA receptors
- excess glutamate also causes cellular death due to influx of calcium into cells via constant glutamate interact

Postsynaptic inhibition signals are also detected, further masking signal transduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Memantine

A

MOA: non-competitive NMDA receptor antagonist (blocks calcium pores)
- blocks NMDA receptors and inhibits glutamate induced excitotoxicity that is linked to neuronal cell death in Alzheimer’s

Pregnancy B

Indications:
- mild to severe Alzheimer’s

ADRs:

  • dizziness
  • confusion
  • Headache
  • no noteworthy contraindication
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Parkinson’s disease pathology

A

Decrease in dopamine neurons in substantia Nigra pars reticulata and the corpus striatum spiny neurons

Causes increased GABA release and increased ACh

  • results in janky movements
  • to fix, use anticholinergics to balance the levels of dopamine and ACh (without drugs, Parkinson’s patients are normally ACh > dopamine) or increase level of dopamine levels to ACh levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the main dopamine precursor?

A

L-DOPA

- gold standard for Parkinson’s disease tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why is levodopa usually co-administered with carbidopa?

A

Without carbidopa (which is a peripheral AAD inhibitor) most of L-DOPA gets converted to dopamine in the periphery rather than the CNS (<1% actually makes it to the CNS without carbidopa)

When co-administered, 10% reaches CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Can carbidopa affect CNS AAD enzymes?

A

No it cannot cross the BBB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ADRs of L-DOPA

A

Dyskinesia (most common)

Anorexia and Nausea/vomiting
- less common with combo carbidopa

Cardiac arrhythmias

Behavioral abnormalities
- more common with combo carbidopa

Contraindications:

  • psychotic treatments
  • active peptic ulcers
  • patients with history’s of melanomas (can reactive them)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dopamine receptor agonists

Bromocriptine, pramipexole, ropinirole. Apomorphine

A

MOA: synthetic mimic of dopamine that binds to dopamine receptors and generate dopamine function (motor control)

ADRs/contraindications

  • nausea/vomiting
  • drowsiness
  • behavioral effects
  • orthostatic hypotension
  • pulmonary fibrosis (long term only)
  • hypoglycemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MAO inhibitors

selegiline, rasagiline

A

MOA: inhibits dopamine metabolism by blocking monoamine oxidase (MAO) enzymes

Used as adjunct for levodopa/carbidopa

Used for early Parkinson’s patients only

ADRs:

  • dyskinesia and hallucinations
  • nausea/vomiting
  • tyramine toxicity
  • serotonin syndrome
  • insomnia (selegiline only)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

COMT inhibitors

Tolcapone, entacapone

A

MOA: inhibits dopamine metabolism by blocking catechol-O-methytransferase

Most often used as adjunct for levodopa/carbidopa

For early Parkinson’s only

tolcapone can work in both periphery and CNS, whereas entacapone can only work in the periphery

ADRs:

  • levodopa toxicity (increases effects)
  • ab pain
  • diarrhea
  • ortho hypotension
  • nausea/vomiting
  • orange urine (entacapone only)
  • Hepatotoxicty (Tolcapone only)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why would one only want to use entacapone (periphery acting only) vs tolcapone (CNS and periphery acting) ?

A

To keep L-DOPA levels high in the periphery (tolcapone doesnt work as well in the periphery as entacapone).

Also tolcapone has serious hepatotoxicty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Anticholinergics for Parkinson’s

A

Benztropine, trihexyphenidyl, scopolamine

MOA: restores balance of GABAergic signaling by antagonizing Muscarinic receptors

ADRs: (significant amount)

  • sedation and confusion (especially high in the elderly)
  • nausea
  • urinary dysfunction
  • xerostomia
  • blurred vision
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Amantadine

A

MOA: idiopathic, is normally used for antiviral vaccination for flu.
- hypothesized to antagonize NMDA receptors and D2 neurons

Can be used in Parkinson’s for modest, short lived, benefit in tremor/rigidity and bradykinesia

ADRs:

  • anti-SLUD
  • restlessness
  • insomnia
  • depression
  • hallucinations
  • peripheral edema
  • livedo reticularis (lace like purple lesions of the lower extremities)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ALS (amyotrophic lateral sclerosis)

A

Kills motor nerve cells which causes muscle atrophy over time

Treated via edaravone and riluzole

17
Q

Edaravone

A

MOA: idiopathic, hypothesized to be an antioxidant for oxidative stress damage for motor neurons
- decreases caspase-3 production due to increasing levels of SMN protein

Pregnancy is not fully known, but believed to be teratogenic (is in animals)

Indications for ALS treatment

ADRs:

  • contusion
  • abnormal gait
  • dermatitis
  • respiratory failure
  • anaphylactic reactions

*is stupid expensive and because of this is usually only used after failure of riluzole

18
Q

Riluzole

A

MOA: a glutamate antagonist that inhibits glutamate neurotransmission. Does this by inhibiting release of glutamic acid and blocking NMDA receptors

Pregnant C

Used in treatment for ALS and Huntington’s

ADRs:

  • HTN
  • nausea/vomiting
  • increases liver enzymes (mimics liver failure)
  • asthenia
  • oral hypoesthesia
  • hepatitis
  • respiratory depression
19
Q

Spinal muscular atrophy (SMA)

A

Autosomal recessive disease that results in a deletion of SMN1 and alternative splicing of SMN2 proteins
- results in muscle atrophy overtime

Treated via nusinersen (increases production of properly spliced SMN2 proteins)

20
Q

Nusinersen

A

MOA: antisense oligonucleotide that binds to a specific intron sequence of exon 7 in SMN mRNA.
- blocks splicing silencers and increases production of full-length SMN2 protein

Pregnancy is unknown

Indications = SMA only

ADRs:

  • backache/headache
  • increased chances of fevers and lower respiratory infections (pneumonia)
  • proteinuria
  • thrombocytopenia
  • atelectasis
  • can mess with INR levels